Mechanistic insights into PM2.5-induced myopia in mice: Role of NRF2/HIF-1α signaling and therapeutic potential of sulforaphane

Read full text
Authors: Bo Liu, Xueting Yao, Chunqiong Dong, Jiayi Ma, Jinfei Wei, Qinying Huang, Yichao Fan, Junhao He, Min Li, Yi-Xiang Wang, Dai Jz
Cited by: 1
References: 39

Abstract

Particulate matter 2.5 (PM 2.5 ) has been implicated in the development of myopia. This study aimed to elucidate the molecular mechanisms through which PM 2.5 exposure influences myopia progression. We integrated Mendelian randomization (MR) analysis of large-scale genetic data, revealing a significant association between particulate matter air pollution (PMAP) and myopia risk (OR = 1.065, 95 % CI: 1.033–1.098; P = 4.73× 10⁻⁵). In mice, ocular PM 2.5 exposure induced pathological axial elongation, accompanied by suppression of NRF2 expression. Mechanistic investigations demonstrated that NRF2 directly binds to HIF-1α, inhibiting its transcriptional activity. Using CETSA, we identified sulforaphane as a selective NRF2 stabilizer that mitigates PM 2.5 -induced myopia progression in mice. These findings present genetic epidemiological evidence supporting a causal association between PMAP exposure and myopia, elucidate a molecular mechanism by which PM 2.5 mediates oxidative stress via the NRF2/HIF-1α signaling axis, and identify sulforaphane as a potential therapeutic agent targeting NRF2, thereby offering novel strategies for the prevention and treatment of environmentally associated myopia. • PMAP is casually associated with the risk of myopia by the Mendelian Randomization (MR) study. • PM2.5 promotes myopia progression through the NRF2/HIF-1α signaling axis. • Pharmacological targeting NRF2 as a novel strategy for PM2.5-induced Myopia.

Fields of Study & Subjects

Genomics phytochemicals and oxidative stress Air Quality and Health Impacts Atmospheric chemistry and aerosols

Publication details

Journal / source
Ecotoxicology and Environmental Safety
Publisher
Elsevier BV
Volume
311
Pages
119889–119889
Publication date
1 February 2026
Language
EN